MedTrace Logo

Entia Liberty: Accuracy and Precision

NCT05025124 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 530

Last updated 2023-01-27

No results posted yet for this study

Summary

This study forms part of Entia's clinical evidence for regulatory submission. This study evaluates Entia Liberty's performance claims with venous blood compared to the gold standard clinical laboratory haematology analysers. Excess blood flagged by the laboratory meeting our requirements will be tested on the Entia Liberty device and have its results compared against the laboratory results. Samples will also be flagged for precision testing (same blood sample, split into 10 Entia Liberty samples).

Conditions

Interventions

DEVICE

Entia Liberty

Home monitoring system

Sponsors & Collaborators

  • Entia Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-03
Primary Completion
2022-12-14
Completion
2022-12-14

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05025124 on ClinicalTrials.gov